• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓移植受者感染人巨细胞病毒后针对人巨细胞病毒的多肽特异性抗体反应。

Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients.

作者信息

Zaia J A, Forman S J, Ting Y P, Vanderwal-Urbina E, Blume K G

出版信息

J Infect Dis. 1986 Apr;153(4):780-7. doi: 10.1093/infdis/153.4.780.

DOI:10.1093/infdis/153.4.780
PMID:3005437
Abstract

Human cytomegalovirus (HCMV) infection continues to be the most important infection occurring after allogeneic bone marrow transplantation (BMT). Although T cell-specific antiviral immunity appears to be necessary for control of the infection, the humoral immune reaction also contributes to a complete immune response. In this paper we report our findings concerning the antibody response to the individual polypeptides of HCMV in patients who had undergone BMT and subsequently had displayed evidence of HCMV infection. Sera obtained from the subjects during and after HCMV viremia were studied by using both a radioimmunoprecipitation assay and an immunoblot assay, and the results were compared with the pattern of antibody response in normal individuals. The results show that the BMT patient can make antibodies to individual proteins of HCMV in a pattern similar to that displayed by persons with natural infection. The polypeptide-specific antibody response present most frequently was directed to proteins of 64 kDa, 50 kDa, and 36 kDa. Some BMT recipients also produced antibody to a wide range of HCMV proteins: 183 kDa, 155 kDa, 130 kDa, 110 kDa, 92 kDa, 86 kDa, 74 kDa, 71 kDa, 69 kDa, 39-44 kDa, 33 kDa, and 29 kDa.

摘要

人巨细胞病毒(HCMV)感染仍然是异基因骨髓移植(BMT)后发生的最重要的感染。尽管T细胞特异性抗病毒免疫似乎是控制感染所必需的,但体液免疫反应也有助于形成完整的免疫应答。在本文中,我们报告了关于接受BMT并随后出现HCMV感染证据的患者对HCMV各个多肽的抗体反应的研究结果。通过放射免疫沉淀试验和免疫印迹试验对受试者在HCMV病毒血症期间及之后获得的血清进行了研究,并将结果与正常个体的抗体反应模式进行了比较。结果表明,BMT患者能够以与自然感染个体相似的模式产生针对HCMV各个蛋白质的抗体。最常出现的多肽特异性抗体反应针对的是64 kDa、50 kDa和36 kDa的蛋白质。一些BMT受者还产生了针对多种HCMV蛋白质的抗体:183 kDa、155 kDa、130 kDa、110 kDa、92 kDa、86 kDa、74 kDa、71 kDa、69 kDa、39 - 44 kDa、33 kDa和29 kDa。

相似文献

1
Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients.骨髓移植受者感染人巨细胞病毒后针对人巨细胞病毒的多肽特异性抗体反应。
J Infect Dis. 1986 Apr;153(4):780-7. doi: 10.1093/infdis/153.4.780.
2
Antibody responses to human cytomegalovirus-specific polypeptides studied by immunoblotting in relation to viral load during cytomegalovirus infection.
J Med Virol. 1993 Jan;39(1):80-7. doi: 10.1002/jmv.1890390115.
3
Transfer of humoral immunity against cytomegalovirus proteins following transplantation of T-cell-depleted allogeneic bone marrow from seropositive donors.
J Med Virol. 1993 Oct;41(2):150-8. doi: 10.1002/jmv.1890410211.
4
Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.采用补体结合试验(CF)、酶联免疫吸附测定(ELISA)和免疫印迹技术对巨细胞病毒抗体进行比较。
Arch Immunol Ther Exp (Warsz). 1987;35(3):313-9.
5
Human cytomegalovirus neutralizing antibody response in Japanese children with bone marrow transplantation.日本骨髓移植儿童的人巨细胞病毒中和抗体反应
Tohoku J Exp Med. 1994 Sep;174(1):11-7. doi: 10.1620/tjem.174.11.
6
Antibodies to human cytomegalovirus structural polypeptides during primary infection.原发性感染期间针对人巨细胞病毒结构多肽的抗体
J Virol Methods. 1988 Dec;22(2-3):309-17. doi: 10.1016/0166-0934(88)90113-9.
7
Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.异基因骨髓移植后人类巨细胞病毒感染及疾病的管理
Haematologica. 1999 Jan;84(1):71-9.
8
Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.通过定量竞争PCR诊断和监测骨髓移植受者的人巨细胞病毒感染
Exp Clin Transplant. 2006 Jun;4(1):470-4.
9
Analysis by immunoblotting of human cytomegalovirus antibody in sera of renal transplant recipient.肾移植受者血清中人巨细胞病毒抗体的免疫印迹分析。
J Med Virol. 1987 Apr;21(4):339-46. doi: 10.1002/jmv.1890210406.
10
Kinetics of the antibody response against human cytomegalovirus-specific proteins in allogeneic bone marrow transplant recipients.
J Infect Dis. 1998 Nov;178(5):1233-43. doi: 10.1086/314428.

引用本文的文献

1
Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice.人巨细胞病毒pp65低基质蛋白:系统性红斑狼疮患者的体液免疫原及NZB/W F1小鼠自身抗体促进剂。
Clin Exp Immunol. 2006 Jan;143(1):167-79. doi: 10.1111/j.1365-2249.2005.02974.x.
2
Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins.人巨细胞病毒UL82(pp71)和UL83(pp65)基质磷蛋白的假定鼠巨细胞病毒同源物的鉴定、分析及进化关系
J Virol. 1996 Nov;70(11):7929-39. doi: 10.1128/JVI.70.11.7929-7939.1996.
3
Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.
对人巨细胞病毒感染的体液免疫反应:免疫球蛋白类别及IgG亚类抗体对人巨细胞病毒早期和晚期抗原反应的诊断潜力
Clin Investig. 1993 Apr;71(4):270-6. doi: 10.1007/BF00184725.
4
Viral infections in severely immunocompromised cancer patients.严重免疫功能低下癌症患者的病毒感染
Support Care Cancer. 1994 Nov;2(6):355-68. doi: 10.1007/BF00344048.
5
Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus.人类针对巨细胞病毒产生的低基质蛋白(pp65)的抗体反应性。
Clin Diagn Lab Immunol. 1995 May;2(3):325-9. doi: 10.1128/cdli.2.3.325-329.1995.
6
Molecular biology and immunology of cytomegalovirus.巨细胞病毒的分子生物学与免疫学
Biochem J. 1987 Jan 15;241(2):313-24. doi: 10.1042/bj2410313.
7
Identification and procaryotic expression of the gene coding for the highly immunogenic 28-kilodalton structural phosphoprotein (pp28) of human cytomegalovirus.人巨细胞病毒高免疫原性28千道尔顿结构磷蛋白(pp28)编码基因的鉴定及原核表达
J Virol. 1988 Jul;62(7):2243-50. doi: 10.1128/JVI.62.7.2243-2250.1988.
8
Procaryotic expression of phosphorylated tegument protein pp65 of human cytomegalovirus and application of recombinant peptides for immunoblot analyses.人巨细胞病毒磷酸化被膜蛋白pp65的原核表达及重组肽在免疫印迹分析中的应用
J Clin Microbiol. 1990 Jun;28(6):1229-35. doi: 10.1128/jcm.28.6.1229-1235.1990.
9
Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus.人巨细胞病毒糖蛋白gp55上线性抗原位点的分布
J Virol. 1991 Jan;65(1):138-46. doi: 10.1128/JVI.65.1.138-146.1991.
10
Comparative sequence analysis of human cytomegalovirus strains.人巨细胞病毒毒株的比较序列分析
J Clin Microbiol. 1991 Nov;29(11):2494-502. doi: 10.1128/jcm.29.11.2494-2502.1991.